Kiora Pharmaceuticals Inc <KPRX.OQ> expected to post a loss of 60 cents a share - Earnings Preview
Kiora Pharmaceuticals Inc KPRX.OQ KPRX.O is expected to show a rise in quarterly revenue when it reports results on August 7 (estimated) for the period ending June 30 2025
The Encinitas California-based company is expected to report a 3,650.0% increase in revenue to $750 thousand from $20 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Kiora Pharmaceuticals Inc is for a loss of 60 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Kiora Pharmaceuticals Inc is $11.00, about 76.9% above its last closing price of $2.54
This summary was machine generated August 5 at 14:37 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
